[Detection of pregnancy-specific beta 1-glycoproteins (SP1) and pregnancy-associated plasma protein A (PAPP-A) in maternal serum. Diagnostic significance in intrauterine fetal retardation]

[Detection of pregnancy-specific beta 1-glycoproteins (SP1) and pregnancy-associated plasma protein A (PAPP-A) in maternal serum. Diagnostic significance in intrauterine fetal retardation] Research Abstract Details 

Research Abstract Table of Contents

Jump to the:

[Detection of pregnancy-specific beta 1-glycoproteins (SP1) and pregnancy-associated plasma protein A (PAPP-A) in maternal serum. Diagnostic significance in intrauterine fetal retardation] Abstract Text:

V Briese,W Straube,

The problem was to prove the value of SP1 (pregnancy specific beta 1-glycoprotein) and PAPP-A (pregnancy-associated plasmaprotein A) estimations in maternal serum samples for diagnosis of intrauterine growth retardation (IUGR). After delivery the pediatrician confirmed the diagnose of IUGR by means of clinical assessment. SP1 was estimated in 25 serum samples from 8 patients with IUGR and in 36 samples from healthy women by means of single radial immunodiffusion (24h-RID). Low SP1-values were found in serum samples from 4 patients with IUGR. There was a significant correlation (p less than 0,01) between SP1 concentrations and pregnancy weeks only in the control group. The regression line of the IUGR group was not different from 0 significantly. The estimations of PAPP-A were performed in 17 serum samples from 6 patients with IUGR. 24 serum samples from 12 healthy pregnant women were applied to control group. There was no difference between the 2 groups. PAPP-A is not suitable for diagnosis of IUGR.

[Detection of pregnancy-specific beta 1-glycoproteins (SP1) and pregnancy-associated plasma protein A (PAPP-A) in maternal serum. Diagnostic significance in intrauterine fetal retardation] Publishing Authors By Initials

V Briese,W Straube,

For similar diagnosis: diagnostic techniques and procedures: diagnostic techniques, obstetrical and gynecological: prenatal diagnosis research abstracts see: diagnosis: diagnostic techniques and procedures: diagnostic techniques, obstetrical and gynecological: prenatal diagnosis research

PUBMED ID PMID:

MEDLINE DATE:

[Detection of pregnancy-specific beta 1-glycoproteins (SP1) and pregnancy-associated plasma protein A (PAPP-A) in maternal serum. Diagnostic significance in intrauterine fetal retardation] Journal Published:

PUBLICATION TYPE: Journal Article

Journal: Zentralblatt für Gynäkologie

VOLUME: 106

Page Numbers: 517-23

Journal Abbreviation: Zentralbl Gynakol

ISSN: 0044-4197

DAY: 11

MONTH: 02

YEAR: 1984

[Detection of pregnancy-specific beta 1-glycoproteins (SP1) and pregnancy-associated plasma protein A (PAPP-A) in maternal serum. Diagnostic significance in intrauterine fetal retardation] Information

Number of References:

LANGUAGE: ger

NlmUniqueID: 21820100

[Detection of pregnancy-specific beta 1-glycoproteins (SP1) and pregnancy-associated plasma protein A (PAPP-A) in maternal serum. Diagnostic significance in intrauterine fetal retardation] Keywords Mesh Terms:

KEYWORDS: Prenatal Diagnosis

MESH TERMS: methods

Chemical & Substance for Abstract: [Detection of pregnancy-specific beta 1-glycoproteins (SP1) and pregnancy-associated plasma protein A (PAPP-A) in maternal serum. Diagnostic significance in intrauterine fetal retardation] Information

Substance Name: Pregnancy-Associated Plasma Protein-A

Registry Number: EC 3.4.24.-

Grant and Affiliation Information for [Detection of pregnancy-specific beta 1-glycoproteins (SP1) and pregnancy-associated plasma protein A (PAPP-A) in maternal serum. Diagnostic significance in intrauterine fetal retardation]

AFFILIATION:

Country: GERMANY, EAST

AGENCY:

GRANT:

ACRONYM:

MEDLINETA: Zentralbl Gynakol

REFSOURCE:

DATABASENAME:

ACCESSION NUMBER:

Number Hits: 0

Detection of pregnancy-specific beta 1-glycoproteins SP1 and pregnancy-associated plasma protein A PAPP-A in maternal serum Diagnostic significance in intrauterine fetal retardation Related Publications

• A concentric-ring equivalent phased array method to model fields of large axisymmetric ultrasound transducers.
• Barry Straube on the CMS Office of Clinical Standards and Quality. Interview by Pamela K Scarrow.
• Botulinum toxin type-A therapy in cluster headache: an open study.
• Chlamydia pneumoniae infection of aortic smooth muscle cells reduces platelet-derived growth factor receptor-beta expression.
• Commentary. The imperatives for change in the US health care payment and delivery systems are clear.
• Decreased sTNF-RI in migraine patients?
• FES cycling reduces spastic muscle tone in a patient with multiple sclerosis.
• Motor cortex excitability in patients with migraine with aura and hemiplegic migraine.
• Partial improvement of headache in a patient with spontaneous cervical cerebrospinal fluid (CSF) leakage after lumbar blood patch.
• Recognition and evaluation of emotional prosody in individuals with generalized social phobia: a pilot study.
• Reversible dementia and corresponding CSF alterations due to intraspinal lumbosacral metastasis of a prostate carcinoma.
• T-cell subsets and expression of integrins in peripheral blood of patients with migraine.
• Treatment of cluster headache with topiramate: effects and side-effects in five patients.
• Velocity scaling of cue-induced smooth pursuit acceleration obeys constraints of natural motion.
• [Demonstration of immunoglobulins, glycoproteins and beta 2 microglobulin in ovarian cysts and cystic ovarian tumors]
• [Detection of pregnancy-specific beta 1-glycoprotein (SP1), of proteins of the "pregnancy zone" (PZ), of pregnancy-associated plasma protein A (PAPP-A) with 24-hour radial immunodiffusion. Detection of pregnancy-specific beta 1-glycoprotein (SP1) with tur
• [Detection of pregnancy-specific beta 1-glycoproteins (SP1) and pregnancy-associated plasma protein A (PAPP-A) in maternal serum. Diagnostic significance in intrauterine fetal retardation]
• [Detection of secretory IgA in urine of patients with urinary tract infection in pregnancy and puerperium (author's transl)]
• [Detection of secretory immunoglobulin A in cervical secretion and in cervicovaginal irrigation fluids]
• [Detection of secretory immunoglobulin A in vaginal fluid of hysterectomised women]
• [Estimation of secretory immunoglobulin A in serum of pregnant women (author's transl)]
• [Immunoglobulin M and alpha 2-macroglobulin in the amniotic fluid in neural tube defects]
• [Maternal serum IgA in intrauterine fetal growth retardation]
• [Mission oriented diagnostic real-time PCR.]
• [Not Available.]
• [Primary headaches and the influence of inflammatory diseases of the CNS and their respective immunmodulatory therapy]
• [Relation of AFP and glucose in amniotic fluid]
• [Secretory immunoglobulin A (S-IgA) in amniotic fluid and in pharyngeal mucus and urine of newborn infants]
• [Secretory immunoglobulin A (S-IgA)/immunoglobulin A (IgA) ratio in cervico-vaginal lavage fluids]
• [Serum concentration of pregnancy-associated alpha 2-glycoprotein (alpha 2-PAG, protein of pregnancy zone, PZ) in patients with dermatological diseases (author's transl)]